Compare FBIZ & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBIZ | CYRX |
|---|---|---|
| Founded | 1909 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.2M | 472.7M |
| IPO Year | N/A | N/A |
| Metric | FBIZ | CYRX |
|---|---|---|
| Price | $57.44 | $10.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $59.67 | $12.83 |
| AVG Volume (30 Days) | 21.9K | ★ 340.5K |
| Earning Date | 01-29-2026 | 03-03-2026 |
| Dividend Yield | ★ 2.05% | N/A |
| EPS Growth | ★ 30.77 | N/A |
| EPS | ★ 6.07 | 1.27 |
| Revenue | $158,054,000.00 | ★ $243,795,000.00 |
| Revenue This Year | $19.24 | N/A |
| Revenue Next Year | $7.41 | $9.12 |
| P/E Ratio | $9.34 | ★ $8.22 |
| Revenue Growth | 12.70 | ★ 41.27 |
| 52 Week Low | $42.18 | $4.58 |
| 52 Week High | $59.86 | $11.45 |
| Indicator | FBIZ | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 52.01 |
| Support Level | $55.24 | $10.39 |
| Resistance Level | $59.86 | $11.45 |
| Average True Range (ATR) | 1.61 | 0.50 |
| MACD | 0.19 | -0.01 |
| Stochastic Oscillator | 45.36 | 46.85 |
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.